Medison Pharma announces multi-regional agreement with argenx to commercialize Efgartigimod

Efgartigimod is approved in the United States as VYVGART for the treatment of adults with generalized myasthenia gravis

Agilent to improve analysis speeds of genomics bioinformatics

Cloud-native Alissa data analysis SaaS platform empowers clinical labs and researchers to scale operations with parallel analysis of genomic data

C2i Genomics and Karkinos Healthcare partner to bring AI-powered cancer detection and monitoring to India

C2i Genomics expands its global reach and brings the first whole-genome sequencing minimal residual disease test to India

RH Capital announces investments to improve women’s health

RH Capital, a leading women's health venture capital fund, announced three new investments to improve health outcomes for women in the US.

Lockwood acquires medical animation studio ‘Random42’ from Graphite Capital

The partnership between Lockwood and Random42 expands the capabilities and geographic footprint for both organizations.

David Kendall named Zealand Pharma CMO

Follows Zealand Pharma’s appointment of Adam Steensberg as CEO and decision to refocus strategy

Gilead Sciences appoints Stacey Ma as EVP, Pharmaceutical Development and Manufacturing

Taiyin Yang, PhD, Executive Vice President, Pharmaceutical Development and Manufacturing to Retire After 29 Years at Gilead

Ovensa and Celanese to collaborate to advance precision drug delivery

Digitalization of pharma labs will help in better decision making: Experts

Besides enhancing workflow operations by connecting scientists with their lab instruments and data, digitalization holds the potential to acceleratee long-term business growth

USFDA approves Omeprazole capsules to prevent heartburn

Perrigo expects to launch Omeprazole Minis later this year